Spirepoint Private Client LLC Lowers Stake in Cigna Group $CI

Key Points

• Spirepoint Private Client LLC cut its stake in Cigna by 95.9% in Q4, selling 26,614 shares and leaving 1,139 shares valued at about $313,000.
• Company insiders Nicole S. Jones and Everett Neville sold 2,307 and 1,719 shares respectively on March 2 at roughly $288.91 each, and insiders now own about 0.60% of the stock.
• Cigna beat Q4 expectations with EPS of $8.08 (vs. $7.88 est.) and revenue of $72.5B (+10.4% YoY), and raised its quarterly dividend to $1.56 ($6.24 annual, ~2.3% yield).

Spirepoint Private Client LLC lowered its stake in shares of Cigna Group (NYSE:CI - Free Report) by 95.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,139 shares of the health services provider's stock after selling 26,614 shares during the period. Spirepoint Private Client LLC's holdings in Cigna Group were worth $313,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Harbor Capital Advisors Inc. boosted its position in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider's stock valued at $26,000 after buying an additional 49 shares during the period. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group during the fourth quarter worth about $28,000. Collier Financial purchased a new stake in shares of Cigna Group during the third quarter worth approximately $34,000. Lodestone Wealth Management LLC purchased a new stake in shares of Cigna Group during the fourth quarter worth approximately $32,000. Finally, Founders Capital Management increased its stake in shares of Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider's stock worth $44,000 after buying an additional 53 shares during the period. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

Cigna Group Price Performance

Cigna Group stock opened at $271.55 on Friday. The stock has a market cap of $71.56 billion, a P/E ratio of 12.24, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. The company has a fifty day simple moving average of $276.36 and a 200-day simple moving average of $278.63. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to analysts' expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were paid a dividend of $1.56 per share. The ex-dividend date was Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. This is an increase from Cigna Group's previous quarterly dividend of $1.51. Cigna Group's dividend payout ratio (DPR) is 28.13%.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent research reports. Guggenheim restated a "buy" rating and set a $318.00 target price on shares of Cigna Group in a research note on Monday, February 2nd. Royal Bank Of Canada cut their target price on shares of Cigna Group from $344.00 to $333.00 and set an "outperform" rating on the stock in a research note on Friday, February 6th. UBS Group reaffirmed a "buy" rating and set a $375.00 price objective on shares of Cigna Group in a research report on Monday, February 9th. Sanford C. Bernstein raised shares of Cigna Group from a "market perform" rating to an "outperform" rating and lifted their price objective for the stock from $307.00 to $358.00 in a research report on Thursday, March 12th. Finally, Zacks Research raised shares of Cigna Group from a "strong sell" rating to a "hold" rating in a research report on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $333.11.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.